About FDA
Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month
Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.
Information is current as of March 31, 2023.
Fiscal Year - 2023

Time | Target | Percentage |
---|---|---|
Oct 2022 | N/A | 80 |
Nov 2022 | N/A | 78 |
Dec 2022 | N/A | 90 |
Jan 2023 | N/A | 93 |
Feb 2023 | N/A | 8 |
Mar 2023 | N/A | 33 |
Apr 2023 | N/A | TBD |
May 2023 | N/A | TBD |
Jun 2023 | N/A | TBD |
Jul 2023 | N/A | TBD |
Aug 2023 | N/A | TBD |
Sep 2023 | N/A | TBD |
FY 2023 YTD: 69%
Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month
Fiscal Year - 2023

Time | Target | Number |
---|---|---|
Oct 2022 | N/A | 12 |
Nov 2022 | N/A | 7 |
Dec 2022 | N/A | 18 |
Jan 2023 | N/A | 14 |
Feb 2023 | N/A | 1 |
Mar 2023 | N/A | 3 |
Apr 2023 | N/A | TBD |
May 2023 | N/A | TBD |
Jun 2023 | N/A | TBD |
Jul 2023 | N/A | TBD |
Aug 2023 | N/A | TBD |
Sep 2023 | N/A | TBD |
FY 2023 YTD: 55
Total number of regulatory cases referred to OFS in the month that are due within the month
Fiscal Year - 2023

Time | Target | Number |
---|---|---|
Oct 2022 | N/A | 15 |
Nov 2022 | N/A | 9 |
Dec 2022 | N/A | 20 |
Jan 2023 | N/A | 15 |
Feb 2023 | N/A | 12 |
Mar 2023 | N/A | 9 |
Apr 2023 | N/A | TBD |
May 2023 | N/A | TBD |
Jun 2023 | N/A | TBD |
Jul 2023 | N/A | TBD |
Aug 2023 | N/A | TBD |
Sep 2023 | N/A | TBD |
FY 2023 YTD: 80
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.